| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, -, Pack: 2 pre-filled syringes + 2 safety needles |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
886.62 |
177.32 |
1063.94 |
4% |
10.00 |
896.62 |
179.32 |
1075.94 |
16% |
25.00 |
921.62 |
184.32 |
1105.94 |
корекц. Решение НСР-3464/16.05.2014 |
НСР-3307/24.04.2014; НСР-14906/25.01.2018 |
09.02.2018 |
02.03.2018 |
Неактивен |
2765 |
| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, -, Pack: 2 pre-filled syringes + 2 safety needles |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
938.76 |
187.75 |
1126.51 |
4% |
10.00 |
948.76 |
189.75 |
1138.51 |
16% |
25.00 |
973.76 |
194.75 |
1168.51 |
корекц. Решение НСР-3464/16.05.2014 |
НСР-3307/24.04.2014 |
08.05.2014 |
08.05.2014 |
Неактивен |
2765 |
| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, mg, Pack: 2 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
945.33 |
189.07 |
1134.40 |
4% |
10.00 |
955.33 |
191.07 |
1146.40 |
16% |
25.00 |
980.33 |
196.07 |
1176.40 |
|
НСР-1037/23.08.2013 |
09.09.2013 |
09.09.2013 |
Неактивен |
2765 |
| Fulvestrant |
EU/1/03/269/001 |
Faslodex, Solution for injection, 250, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
469.40 |
93.88 |
563.28 |
4% |
10.00 |
479.40 |
95.88 |
575.28 |
16% |
25.00 |
504.40 |
100.88 |
605.28 |
Цената се заличава с решение НСР-3636/29.05.2014 ( в сила от 13.06.2014) |
НСР-79/07.06.2013 |
02.07.2013 |
02.07.2013 |
Заличен |
1880 |
| Fulvestrant |
EU/1/03/269/001 |
Faslodex, Solution for injection, 250, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
685.30 |
137.06 |
822.36 |
4% |
10.00 |
695.30 |
139.06 |
834.36 |
16% |
25.00 |
720.30 |
144.06 |
864.36 |
|
КЦРР-869/26.06.2012 |
24.07.2012 |
24.07.2012 |
Неактивен |
1880 |
| Fulvestrant |
EU/1/03/269/001 |
Faslodex, Solution for injection, 250, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
697.08 |
139.42 |
836.49 |
6% |
15.00 |
712.08 |
142.42 |
854.49 |
18% |
30.00 |
742.08 |
148.42 |
890.49 |
|
КЦ-389/07.01.2009 |
26.01.2009 |
26.01.2009 |
Неактивен |
1880 |
| factor VIII inhibitor bypassyng activity |
20150284 |
Feiba, Powder and solvent for solution for infusion, 25 U/ml (500 U), -, Pack: 1 vial 500 U powder for solution for infusion+1 vial 20 ml water for injection+1 administration ste |
Baxalta Innovations GmbH, Австрия |
Baxter AG, Австрия |
632.40 |
126.48 |
758.88 |
4% |
10.00 |
642.40 |
128.48 |
770.88 |
16% |
25.00 |
667.40 |
133.48 |
800.88 |
|
НСР-13563/25.08.2017 |
09.09.2017 |
02.10.2017 |
Неактивен |
15828 |
| factor VIII inhibitor bypassyng activity |
20150284 |
Feiba, Powder and solvent for solution for infusion, 25 U/ml (500 U), -, Pack: 1 vial 500 U powder for solution for infusion+1 vial 20 ml water for injection+1 administration set |
Baxalta Innovations GmbH, Австрия |
Baxter AG, Австрия |
625.26 |
125.05 |
750.31 |
4% |
10.00 |
635.26 |
127.05 |
762.31 |
16% |
25.00 |
660.26 |
132.05 |
792.31 |
|
НСР-13563/25.08.2017; НСР-15794/04.06.2018 (предварително изпълнение) |
04.06.2018 |
02.07.2018 |
Активен |
15828 |
| factor VIII inhibitor bypassyng activity |
9700043 |
Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set |
Baxter AG, Австрия |
Baxter AG - Austria |
625.26 |
125.05 |
750.31 |
4% |
10.00 |
635.26 |
127.05 |
762.31 |
16% |
25.00 |
660.26 |
132.05 |
792.31 |
Промяна на обстоятелства НСР-14657/18.12.2017 |
НСР-2195/20.12.2013; НСР-14088/06.10.2017; НСР-15691/17.05.2018 |
01.06.2018 |
02.06.2018 |
Активен |
2439 |
| factor VIII inhibitor bypassyng activity |
9700043 |
Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set |
Baxter AG, Австрия |
Baxter AG - Austria |
632.22 |
126.44 |
758.66 |
4% |
10.00 |
642.22 |
128.44 |
770.66 |
16% |
25.00 |
667.22 |
133.44 |
800.66 |
Промяна на обстоятелства НСР-14657/18.12.2017 |
НСР-2195/20.12.2013; НСР-14088/06.10.2017 |
21.10.2017 |
02.02.2018 |
Неактивен |
2439 |
| factor VIII inhibitor bypassyng activity |
II-16103/ 15.03.2007 |
Feiba NF, -, 500, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter AG - Austria |
639.91 |
127.98 |
767.89 |
4% |
10.00 |
649.91 |
129.98 |
779.89 |
16% |
25.00 |
674.91 |
134.98 |
809.89 |
|
КЦРР-217/27.02.2012 |
13.03.2012 |
13.03.2012 |
Неактивен |
2439 |
| factor VIII inhibitor bypassyng activity |
II-16103/ 15.03.2007 |
Feiba NF, -, 500, IU, Pack: 1 |
Baxter AG, Австрия |
Baxter AG - Austria |
694.32 |
138.86 |
833.18 |
6% |
15.00 |
709.32 |
141.86 |
851.18 |
18% |
30.00 |
739.32 |
147.86 |
887.18 |
|
КЦ-950/10.06.2009 |
30.06.2009 |
30.06.2009 |
Неактивен |
2439 |
| factor VIII inhibitor bypassyng activity |
II-16103/ 15.03.2007 |
Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set |
Baxter AG, Австрия |
Baxter AG - Austria |
632.22 |
126.44 |
758.66 |
4% |
10.00 |
642.22 |
128.44 |
770.66 |
16% |
25.00 |
667.22 |
133.44 |
800.66 |
|
НСР-2195/20.12.2013; НСР-14088/06.10.2017 |
21.10.2017 |
02.11.2017 |
Неактивен |
2439 |
| factor VIII inhibitor bypassyng activity |
II-16103/ 15.03.2007 |
Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set |
Baxter AG, Австрия |
Baxter AG - Austria |
632.40 |
126.48 |
758.88 |
4% |
10.00 |
642.40 |
128.48 |
770.88 |
16% |
25.00 |
667.40 |
133.48 |
800.88 |
|
НСР-2195/20.12.2013 |
06.02.2014 |
06.02.2014 |
Неактивен |
2439 |
| factor VIII inhibitor bypassyng activity |
II-16103/ 15.03.2007 |
Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set |
Baxter AG, Австрия |
Baxter AG - Austria |
632.40 |
126.48 |
758.88 |
4% |
10.00 |
642.40 |
128.48 |
770.88 |
16% |
25.00 |
667.40 |
133.48 |
800.88 |
|
НСР-2195/20.12.2013 |
06.02.2014 |
06.02.2014 |
Неактивен |
2439 |
| Felodipine |
20060847 |
Felicipin, Prolonged release tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Klocke Pharma-Service GmbH, Germany, Siegfried Generics Ltd., Malta, Actavis UK Limited, UK |
5.55 |
1.11 |
6.66 |
7% |
0.39 |
5.94 |
1.19 |
7.13 |
20% |
1.11 |
7.05 |
1.41 |
8.46 |
промяна на обстоятелства КЦPP-579/04.05.2012; НСР-11449/13.01.2017 |
КЦ-279/14.11.2008; НСР-16036/29.06.2018 |
11.12.2008 |
02.08.2018 |
Заличен |
208 |
| Felodipine |
20060847 |
Felicipin, Prolonged release tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Klocke Pharma-Service GmbH, Germany, Siegfried Generics Ltd., Malta, Actavis UK Limited, UK |
5.55 |
1.11 |
6.66 |
7% |
0.39 |
5.94 |
1.19 |
7.13 |
20% |
1.11 |
7.05 |
1.41 |
8.46 |
промяна на обстоятелства КЦPP-579/04.05.2012; Промяна на обстоятелства НСР-11449/13.01.2017 |
КЦ-279/14.11.2008 |
11.12.2008 |
02.02.2017 |
Неактивен |
208 |
| Felodipine |
0057/20,06,2007 |
Felicipin, Prolonged release tablet, 5, mg, Pack: 30 |
Актавис EАД, България |
Klocke Pharma-Service GmbH, Germany, Siegfried Generics Ltd., Malta, Actavis UK Limited, UK |
5.55 |
1.11 |
6.66 |
7% |
0.39 |
5.94 |
1.19 |
7.13 |
20% |
1.11 |
7.05 |
1.41 |
8.46 |
промяна на обстоятелства КЦPP-579/04.05.2012 |
КЦ-279/14.11.2008 |
11.12.2008 |
11.12.2008 |
Неактивен |
208 |
| Felodipine |
4055/23,01,2009 |
Felodipine-Ratiopharm, Prolonged release tablet, 10, mg, Pack: 30 |
Ratiopharm GmbH, Германия |
Merck KGaARatiopharm BV - Холадия; Merckle GmbH - Germany |
8.61 |
1.72 |
10.33 |
7% |
0.60 |
9.21 |
1.84 |
11.05 |
20% |
1.72 |
10.93 |
2.19 |
13.12 |
цената се заличава КЦРР-2931/20.03.2013 |
КЦРР-1847/12.12.2012 г |
08.02.2013 |
08.02.2013 |
Заличен |
1572 |
| Felodipine |
4054/23,01,2009 |
Felodipine-Ratiopharm, Prolonged release tablet, 5, mg, Pack: 30 |
Ratiopharm GmbH, Германия |
Merck KGaARatiopharm BV - Холадия; Merckle GmbH - Germany |
4.13 |
0.83 |
4.96 |
7% |
0.29 |
4.42 |
0.88 |
5.30 |
20% |
0.83 |
5.25 |
1.05 |
6.30 |
цената се заличава КЦРР-2935/20.03.2013 |
КЦРР-1847/12.12.2012 г |
08.02.2013 |
08.02.2013 |
Заличен |
1571 |
| Felodipine |
4055/23,01,2009 |
Felodipine-Ratiopharm, Prolonged release tablet, 10, mg, Pack: 30 |
Ratiopharm GmbH, Германия |
Ratiopharm BV - Холадия; Merckle GmbH - Germany |
9.00 |
1.80 |
10.80 |
7% |
0.63 |
9.63 |
1.93 |
11.56 |
20% |
1.80 |
11.43 |
2.29 |
13.72 |
|
КЦ-803/07.04.2009 |
23.04.2009 |
23.04.2009 |
Неактивен |
1572 |
| Felodipine |
4054/23,01,2009 |
Felodipine-Ratiopharm, Prolonged release tablet, 5, mg, Pack: 30 |
Ratiopharm GmbH, Германия |
Ratiopharm BV - Холадия; Merckle GmbH - Germany |
4.69 |
0.94 |
5.63 |
7% |
0.33 |
5.02 |
1.00 |
6.02 |
20% |
0.94 |
5.96 |
1.19 |
7.15 |
|
КЦ-803/07.04.2009 |
23.04.2009 |
23.04.2009 |
Неактивен |
1571 |
| Felodipine |
20090190 |
FELODIPINE-TCHAIKAPHARMA, Prolonged release tablet, 5, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
„Чайкафарма Висококачествените Лекарства”АД, бул. ”Г. М. Димитров” № 1, гр. София 1172, България |
2.97 |
0.59 |
3.56 |
7% |
0.21 |
3.18 |
0.64 |
3.82 |
20% |
0.59 |
3.77 |
0.75 |
4.52 |
промяна на обстоятелства НСР-11933/06.03.2017; НСР-13121/06.07.2017 |
КЦ-959/15.06.2009; НСР-16802/20.09.2018 |
05.10.2018 |
02.11.2018 |
Активен |
764 |
| Felodipine |
20090190 |
FELODIPINE-TCHAIKAPHARMA, Prolonged release tablet, 5, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
„Чайкафарма Висококачествените Лекарства”АД, бул. ”Г. М. Димитров” № 1, гр. София 1172, България |
4.63 |
0.93 |
5.56 |
7% |
0.32 |
4.95 |
0.99 |
5.94 |
20% |
0.93 |
5.88 |
1.18 |
7.06 |
промяна на обстоятелства НСР-11933/06.03.2017; НСР-13121/06.07.2017 |
КЦ-959/15.06.2009 |
01.07.2009 |
02.08.2017 |
Неактивен |
764 |
| Felodipine |
20090190 |
FELODIPINE-TCHAIKAPHARMA, Prolonged release tablet, 5, mg, Pack: 30 |
Чайкафарма Висококачествените лекарства АД, България |
"Чайка фарма-висококачествените лекарства" АД, гр. Пловдив, България |
4.63 |
0.93 |
5.56 |
7% |
0.32 |
4.95 |
0.99 |
5.94 |
20% |
0.93 |
5.88 |
1.18 |
7.06 |
промяна на обстоятелства НСР-11933/06.03.2017 |
КЦ-959/15.06.2009 |
01.07.2009 |
02.04.2017 |
Неактивен |
764 |